Extracellular vesicle-derived miR-760 as a novel promising candidate biomarker differentiating stable RRMS from SPMS

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system with heterogenous clinical course, lacking non-invasive biomarkers for phenotype differentiation. This study aimed to explore circulating extracellular vesicle (EV)-derived microRNA (miRNA) signatures and related molecular profiles capable of distinguishing stable relapsing-remitting MS (RRMS) from secondary progressive MS (SPMS). Plasma samples were collected from stable RRMS (n = 30), SPMS (n = 30), and healthy controls (HC) (n = 30), followed by total EVs isolation and characterization using transmission electron microscopy, dynamic light scattering, and flow cytometry. RNA was extracted from EVs, and miRNA profiles were analyzed via RNA sequencing and RT-qPCR. Cytokines and neuronal/astroglial injury biomarkers were quantified using the BioPlex system and ELISA. Functional enrichment and network analyses of miRNA targets were performed, alongside logistic regression modeling to explore potential distinguishing features. Four EV-derived miRNAs (miR-760, miR-98-5p, miR-301a-3p, miR-223-3p) showed significant differences (p < 0.05) between stable RRMS and SPMS. An integrative model combining miRNAs with fibroblast growth factor (FGF) basic protein enabled accurate phenotypic differentiation (AUC = 0.942). miR-760 showed the strongest distinctive capacity for stable RRMS. Additionally, miR-98-5p was markedly up-regulated in both stable RRMS and SPMS compared to HC. Network analysis of miRNA targets suggested distinct immunoregulatory patterns across MS phenotypes. Plasma EV-derived miRNAs—particularly miR-760, and miR-98-5p—showed potential as molecular indicators associated with disease phenotype in MS. Integrating EV-miRNA profiling with protein markers support efforts toward more precise stratification of MS patients. Further studies in independent cohorts and functional validation are warranted before clinical translation.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-01-14
DOI
https://doi.org/10.1038/s41598-026-35189-y
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Extracellular vesicle-derived miR-760 as a novel promising candidate biomarker differentiating stable RRMS from SPMS

Łukasz Łaczmański, Sylwia Michlewska, Shamundeeswari Anandan, Radosław Zajdel et al.
Scientific Reports
Extracellular vesicles in disease
article

Extracellular vesicle-derived miR-760 as a novel promising candidate biomarker differentiating stable RRMS from SPMS

Łukasz Łaczmański, Sylwia Michlewska, Shamundeeswari Anandan, Radosław Zajdel, Justyna Raczkowska, Dorota Kujawa, Angela Dziedzic, Elżbieta Miller, Patrycja Nowak, Joanna Saluk, Karina Wasilewska, Marta Gancarek, Lidia Włodarczyk
article en

Abstract

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system with heterogenous clinical course, lacking non-invasive biomarkers for phenotype differentiation. This study aimed to explore circulating extracellular vesicle (EV)-derived microRNA (miRNA) signatures and related molecular profiles capable of distinguishing stable relapsing-remitting MS (RRMS) from secondary progressive MS (SPMS). Plasma samples were collected from stable RRMS (n = 30), SPMS (n = 30), and healthy controls (HC) (n = 30), followed by total EVs isolation and characterization using transmission electron microscopy, dynamic light scattering, and flow cytometry. RNA was extracted from EVs, and miRNA profiles were analyzed via RNA sequencing and RT-qPCR. Cytokines and neuronal/astroglial injury biomarkers were quantified using the BioPlex system and ELISA. Functional enrichment and network analyses of miRNA targets were performed, alongside logistic regression modeling to explore potential distinguishing features. Four EV-derived miRNAs (miR-760, miR-98-5p, miR-301a-3p, miR-223-3p) showed significant differences (p < 0.05) between stable RRMS and SPMS. An integrative model combining miRNAs with fibroblast growth factor (FGF) basic protein enabled accurate phenotypic differentiation (AUC = 0.942). miR-760 showed the strongest distinctive capacity for stable RRMS. Additionally, miR-98-5p was markedly up-regulated in both stable RRMS and SPMS compared to HC. Network analysis of miRNA targets suggested distinct immunoregulatory patterns across MS phenotypes. Plasma EV-derived miRNAs—particularly miR-760, and miR-98-5p—showed potential as molecular indicators associated with disease phenotype in MS. Integrating EV-miRNA profiling with protein markers support efforts toward more precise stratification of MS patients. Further studies in independent cohorts and functional validation are warranted before clinical translation.

Scientific ReportsVol. 16(1)
Haukeland University Hospital (NO), University of Łódź (PL), Medical University of Lodz (PL), Ludwik Hirszfeld Institute of Immunology and Experimental Therapy (PL), University of Bergen (NO)
Uniwersytet Łódzki
Good health and well-being
Openalex Percentile: Top 88%
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.